The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation

被引:55
作者
Hou, ST [1 ]
Cowan, E [1 ]
Walker, T [1 ]
Ohan, N [1 ]
Dove, M [1 ]
Rasqinha, I [1 ]
MacManus, JP [1 ]
机构
[1] Natl Res Council Canada, Inst Biol Sci, Apoptosis Res Grp, Ottawa, ON K1A 0R6, Canada
关键词
adenovirus; caspase; 3; dopamine; E2F1; neuronal apoptosis; p19(ARF);
D O I
10.1046/j.1471-4159.2001.00402.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The E2F1 transcription factor plays an important role in promoting neuronal apoptosis; however, it is not clear how E2F1 does this. Here we show that E2F1 is involved in dopamine (DA)-evoked apoptosis in cerebellar granule neurons (CGNs), E2F1 -/- CGNs and CGNs expressing an antisense E2F1 cDNA were significantly protected from DA-toxicity relative to controls, The neuronal protection was accompanied by significantly reduced caspase 3 activity. E2F1-mediated neuronal apoptosis did not require activation of gene transcription because: (1) ectopic expression of E2F1 or its mutants lacking the transactivation domain induced neuronal apoptosis, whereas an E2F1 mutant lacking the DNA-binding domain did not; (2) under all of these conditions, known E2F1 target genes including cyclin A, cdc2 and p19(ARF) were not induced; and (3) DA-evoked neuronal apoptosis was associated with up-regulated E2F1, but not transcription of its target genes. Finally, E2F1-mediated neuronal apoptosis was associated with reduced nuclear factor (NF)-kappaB DNA-binding activity. Taken together, these data suggest that E2F1 promotes DA-evoked caspase 3-dependent neuronal apoptosis by a mechanism independent of gene transactivation, and this may possibly occur through inhibition of anti-apoptotic genes including NF-kappaB.
引用
收藏
页码:287 / 297
页数:11
相关论文
共 57 条
  • [1] A DIFFERENTIAL EFFICIENCY OF ADENOVIRUS-MEDIATED IN-VIVO GENE-TRANSFER INTO SKELETAL-MUSCLE CELLS OF DIFFERENT MATURITY
    ACSADI, G
    JANI, A
    MASSIE, B
    SIMONEAU, M
    HOLLAND, P
    BLASCHUK, K
    KARPATI, G
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (04) : 579 - 584
  • [2] Adams PD, 1996, CURR TOP MICROBIOL, V208, P79
  • [3] Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells
    Azuma-Hara, N
    Taniura, H
    Uetsuki, T
    Niinobe, M
    Yoshikawa, K
    [J]. EXPERIMENTAL CELL RESEARCH, 1999, 251 (02) : 442 - 451
  • [4] p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells
    Blum, D
    Wu, Y
    Nissou, MF
    Arnaud, S
    Benabid, AL
    Verna, JM
    [J]. BRAIN RESEARCH, 1997, 751 (01) : 139 - 142
  • [5] p21 Is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells
    Brugarolas, J
    Bronson, RT
    Jacks, T
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 141 (02) : 503 - 514
  • [6] Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.3.CO
  • [7] 2-5
  • [8] Dopaminergic cell death induced by MPP+, oxidant and specific neurotoxicants shares the common molecular mechanism
    Chun, HS
    Gibson, GE
    DeGiorgio, LA
    Zhang, H
    Kidd, VJ
    Son, JH
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 76 (04) : 1010 - 1021
  • [9] Cohen G, 2000, ANN NY ACAD SCI, V899, P112
  • [10] Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: Transrepression correlates with acceleration of apoptosis
    Conzen, SD
    Gottlob, K
    Kandel, ES
    Khanduri, P
    Wagner, AJ
    O'Leary, M
    Hay, N
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) : 6008 - 6018